1Hilarius DL,Kloeg PH,van der Wall E,et al.Chemotherapy-induced nausea and vomiting in daily clinical practice:a community hospital-based study.Support[J].Care Cancer,2012,20(1):107-117. 被引量：1
5Eienberg P,Mackintosh FR,Bitch P,et al.Efficacy,safety and pharma-cokinotics of palonosetmn in patients receiving high1y emetogenic cisplatin-based chemotherapy:a dose-ranging clinical study[J].Annals of Oncology,2004,15(2):330-337. 被引量：1
6Hesketh PJ,Van Belle S,Aapro M,et al.Differential involvement of neurotransmitters through the time course of cisplatin induced emesis as revealed by therapy with specific receptor antagonists[J].Eur J Cancer,2003,39(8):1074-1080. 被引量：1
7Shimizu H, Ohtani KI, Tsuchiya T, et al. Aidose reductase m RAN expression is associated with rapid development of diabetic microangiopathy in Japanses type 2 diabetes (T2DM) patient. Diabetes Nutr Metab, 2000, 13:75- 79.). 被引量：1
8Ross AK, Ferrero-Conover D. Anaphylactoid reaction due to the administration of ondansetron in a pediatric neurosurgical patient[J]. Anesth Analg, 1998, 87(4) : 779-780. 被引量：1
9Piraccini G,Stolz R,Tei M,et al.Pharmacokinetic features of a novel 5-HT3-receptor antagonist:palonosetron (RS 25259-197)[J].Proc Am Soc Clin Oncol 2001(20):400a (Abstr 1595). 被引量：1
10Macciocchi A,Gallagher S.A phase II dose-ranging study to assess single intravenous doses of palonosetron for the prevention of highly emetogenic chemotherapy-induced nausea and vomiting[J].Proc Am Soc Clin Oncol,2002(21):471a (Abstr 1480). 被引量：1
